Authors:
JONES JT
BALLINGER MD
PISACANE PI
LOFGREN JA
FITZPATRICK VD
FAIRBROTHER WJ
WELLS JA
SLIWKOWSKI MX
Citation: Jt. Jones et al., BINDING INTERACTION OF THE HEREGULIN-BETA EGF DOMAIN WITH ERBB3 AND ERBB4 RECEPTORS ASSESSED BY ALANINE SCANNING MUTAGENESIS, The Journal of biological chemistry, 273(19), 1998, pp. 11667-11674
Authors:
FITZPATRICK VD
PISACANE PI
VANDLEN RL
SLIWKOWSKI MX
Citation: Vd. Fitzpatrick et al., FORMATION OF A HIGH-AFFINITY HEREGULIN BINDING-SITE USING THE SOLUBLEEXTRACELLULAR DOMAINS OF ERBB2 WITH ERBB3 OR ERBB4, FEBS letters, 431(1), 1998, pp. 102-106
Citation: G. Schaefer et al., GAMMA-HEREGULIN - A NOVEL HEREGULIN ISOFORM THAT IS AN AUTOCRINE GROWTH-FACTOR FOR THE HUMAN BREAST-CANCER CELL-LINE, MDA-MB-175, Oncogene, 15(12), 1997, pp. 1385-1394
Citation: Lc. Chen et al., BOTH OVERLAPPING AND DISTINCT SIGNALING PATHWAYS FOR SOMATOSTATIN RECEPTOR SUBTYPES SSTR1 AND SSTR2 IN PITUITARY-CELLS, The Journal of biological chemistry, 272(30), 1997, pp. 18666-18672
Citation: Vd. Fitzpatrick et Rl. Vandlen, AGONIST SELECTIVITY DETERMINANTS IN SOMATOSTATIN RECEPTOR SUBTYPE-I AND SUBTYPE-II, The Journal of biological chemistry, 269(40), 1994, pp. 24621-24626
Authors:
SLIWKOWSKI MX
SCHAEFER G
AKITA RW
LOFGREN JA
FITZPATRICK VD
NUIJENS A
FENDLY BM
CERIONE RA
VANDLEN RL
CARRAWAY KL
Citation: Mx. Sliwkowski et al., COEXPRESSION OF ERBB2 AND ERBB3 PROTEINS RECONSTITUTES A HIGH-AFFINITY RECEPTOR FOR HEREGULIN, The Journal of biological chemistry, 269(20), 1994, pp. 14661-14665